Third Rock Ventures Leads $165 Million Funding Round for Steve Paul’s Schizophrenia-Focused Biotech Startup - GeneOnline News

The investment supports the latest spinout from Paul, who is known for his work in neuroscience and drug development. This financing round aims to ...